Biogen CEO: ‘Major bottleneck’ still limits Alzheimer’s drug

October 20, 2021

A new Alzheimer’s drug from Biogen brought in only $300,000 in sales during its first full quarter on the market, continuing a slow debut complicated by coverage questions and concerns from doctors.

Turncoat T cells underlie assault on small intestine amid gluten-induced chaos of celiac disease
Wheat, barley and rye contain a protein that can produce severe intestinal symptoms in people with celiac disease, and a team of scientists at Columbia University in New York has now identified distinct signatures of immune system cells that drive the disorder.
In monkey trial, gene therapy shows promise in curbing severe problem drinking
For people with severe alcohol use disorder, a new gene therapy trial could lead to an effective treatment that would involve chemically rebalancing the area of the brain associated with addiction.
Breathe: The shape-shifting ball that supports mental health
A soft ball designed to support mental health by 'personifying' breath has been invented by a computer science student at the University of Bath.
Study finds maintaining stable weight increases longevity among older women
Reaching the age of 90, 95 or 100, known as exceptional longevity, was more likely for women who maintained their body weight after age 60, according to a multi-institutional study led by University of California San Diego. Older women who sustained a stable weight were 1.2 to 2 times more likely to achieve longevity compared to those who experience a weigh loss of 5 percent or more.
Mozart lullaby may ameliorate pain in newborns during heel prick blood test
Playing a Mozart lullaby may help reduce the pain experienced by newborn babies undergoing a heel prick blood test, according to a randomized, blinded clinical trial involving 100 infants published in Pediatric Research.

Biogen CEO: ‘Major bottleneck’ still limits Alzheimer’s drug

Recent Posts

JUST IN